Loncom Pharma's Pazopanib Hydrochloride APIs are pivotal in crafting anti-cancer drugs that inhibit angiogenesis and tumor cell growth. Their versatility in treating soft tissue sarcoma and renal cell carcinoma showcases the innovation of Loncom Pharma's pharmaceutical ingredients.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
